Organization Statistics
Avg Compliance Rate
48.60%
Compliant Trials
486
Incompliant submissions
514
Total Organizations
46697
Total trials
1000
Filter Organizations
Compare Organization Compliance Rates
Showing 300 of 46697 entries
View as:
0.0% Compliant
Total: 3
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 6
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 21
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 24
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 7
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 5
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 4
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 3
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 3
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 34
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 5
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 19
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 17
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 8
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 23
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 20
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 32
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
| Sponsor | Funding Source | Total Trials | Reporting Rate | Compliant Trials | Late Submissions | Compliance Rate | Wilson LCB Score | Email Domain | Created Date |
|---|---|---|---|---|---|---|---|---|---|
| ACTEON Group | - | 3 | 0.0% | 0 | 0 | 0.0% | - | ACTEON Group.temp.org | 2025-07-14 |
| ACU Medical Technologies Ltd | - | 1 | 0.0% | 0 | 0 | 0.0% | - | ACU Medical Technologies Ltd.temp.org | 2025-07-14 |
| ADARx Pharmaceuticals, Inc. | - | 6 | 0.0% | 0 | 0 | 0.0% | - | ADARx Pharmaceuticals, Inc..temp.org | 2025-07-14 |
| ADC Therapeutics S.A. | - | 21 | 0.0% | 0 | 0 | 0.0% | - | ADC Therapeutics S.A..temp.org | 2025-07-14 |
| ADIR Association | - | 24 | 0.0% | 0 | 0 | 0.0% | - | ADIR Association.temp.org | 2025-07-14 |
| ADITYA PAWAR | - | 1 | 0.0% | 0 | 0 | 0.0% | - | ADITYA PAWAR.temp.org | 2025-07-14 |
| ADMA Biologics, Inc. | - | 7 | 0.0% | 0 | 0 | 0.0% | - | ADMA Biologics, Inc..temp.org | 2025-07-14 |
| ADRIANO LAZZARIN, MD | - | 1 | 0.0% | 0 | 0 | 0.0% | - | ADRIANO LAZZARIN, MD.temp.org | 2025-07-14 |
| ADVANCED MARKER DISCOVERY S.L. | - | 5 | 0.0% | 0 | 0 | 0.0% | - | ADVANCED MARKER DISCOVERY S.L..temp.org | 2025-07-14 |
| AEON Biopharma, Inc. | - | 4 | 0.0% | 0 | 0 | 0.0% | - | AEON Biopharma, Inc..temp.org | 2025-07-14 |
| AET Laboratories Private Limited | - | 3 | 0.0% | 0 | 0 | 0.0% | - | AET Laboratories Private Limited.temp.org | 2025-07-14 |
| AEYE Health Inc | - | 3 | 0.0% | 0 | 0 | 0.0% | - | AEYE Health Inc.temp.org | 2025-07-14 |
| AEterna Zentaris | - | 34 | 0.0% | 0 | 0 | 0.0% | - | AEterna Zentaris.temp.org | 2025-07-14 |
| AFT Pharmaceuticals, Ltd. | - | 5 | 0.0% | 0 | 0 | 0.0% | - | AFT Pharmaceuticals, Ltd..temp.org | 2025-07-14 |
| AG Clinic | - | 2 | 0.0% | 0 | 0 | 0.0% | - | AG Clinic.temp.org | 2025-07-14 |
| AGA Clinical Research Associates, LLC | - | 1 | 0.0% | 0 | 0 | 0.0% | - | AGA Clinical Research Associates, LLC.temp.org | 2025-07-14 |
| AGC Biologics S.p.A. | - | 19 | 0.0% | 0 | 0 | 0.0% | - | AGC Biologics S.p.A..temp.org | 2025-07-14 |
| AGI Therapeutics, Inc. | - | 1 | 0.0% | 0 | 0 | 0.0% | - | AGI Therapeutics, Inc..temp.org | 2025-07-14 |
| AGIR à Dom | - | 17 | 0.0% | 0 | 0 | 0.0% | - | AGIR à Dom.temp.org | 2025-07-14 |
| AGIRx Ltd. | - | 1 | 0.0% | 0 | 0 | 0.0% | - | AGIRx Ltd..temp.org | 2025-07-14 |
| AGO Research GmbH | - | 8 | 0.0% | 0 | 0 | 0.0% | - | AGO Research GmbH.temp.org | 2025-07-14 |
| AGO Study Group | - | 23 | 0.0% | 0 | 0 | 0.0% | - | AGO Study Group.temp.org | 2025-07-14 |
| AGUNCO Obstetrics and Gynecology Centre | - | 20 | 0.0% | 0 | 0 | 0.0% | - | AGUNCO Obstetrics and Gynecology Centre.temp.org | 2025-07-14 |
| AHEPA University Hospital | - | 32 | 0.0% | 0 | 0 | 0.0% | - | AHEPA University Hospital.temp.org | 2025-07-14 |
| AHMED ABDULQADER HAMMOUDA ABOU SHALL | - | 1 | 0.0% | 0 | 0 | 0.0% | - | AHMED ABDULQADER HAMMOUDA ABOU SHALL.temp.org | 2025-07-14 |